Here you find all published genome-wide association studies with multiplexed protein traits in blood (pGWAS). If a study is missing from this list, please let me know.
This table was initially published as Supplementary Table 1 in Suhre et al. (2017) and has been updated as of January 01, 2019.
If you are interested in associations at specific loci you may also use the SNiPA block annotation tool [read this post], and if you are looking for associations specific to certain metabolites, try the Proteomics GWAS Server [read this post].
| Reference | Study population | #Samples in study | #Proteins assayed | #pQTLs reported | Platform type |
|---|---|---|---|---|---|
| Melzer et al. (PLoS Genet, 2008) | Population study | 1200 | 42 | 8 | Immuno-assay |
| Lourdusamy et al. (Hum Mol Genet, 2012) | Elderly Europeans | 96 | 778 | 60 | Aptamer-based |
| Johansson et al. (PNAS, 2013) | Two population cohorts | 1060 | 163 | 5 | Mass-spectrometry |
| Kim et al. (PLoS One, 2013) | Altzheimer's disease cohort | 521 | 132 | 28 | Immuno-assay |
| Enroth et al. (Nature Comm, 2014) | Population study | 970 | 77 | 18 | Immuno-assay |
| Kauve et al., PLoS Genet., 2014 | CSF fluid from two Altzheimer's disease cohorts | 574 | 59 | 5 | Immuno-assay for proteins relevant to Altzheimer's disease |
| Liu et al. (Mol Syst Biol, 2015) | Female twins | 113 | 342 | 18 | Mass-spectrometry |
| Sun et al. (PLOS Genetics, 2016) | Current and former smokers with and without COPD (SPIROMICS & COPDGene ) | 1340 | 88 | 527 | Multiplex immuno assays (Myriad-RBM) |
| Deming et al. (Sci Rep, 2016) | Alzheimer cohort | 818 | 146 | 56 | Immuno-assay |
| Solomon et al. (Circ Cardiovasc Genet, 2016) | Population study | 330 | 51 | 27 | Immuno-assay for proteins implicated in cardiovascular diseases |
| Ahola-Olli et al. (Am J Hum Genet, 2017) | Population study | 8293 | 48 | 27 | Immuno-assay for cytokines and growth factors |
| Di Narzo et al. (PLoS Genet, 2017) | Inflammatory bowel disease (IBD) patients | 187 | 1128 | 41 | Aptamer-based |
| Suhre et al. (Nature Comm, 2017) | KORA and QMDiab study (Germany and Qatar) | 1335 | 1124 | 539 | Aptamer-based |
| Sasayama et al. (Hum Mol Genet, 2017) | CSF fluid from a Japanese population | 133 | 1126 | 476 | Aptamer-based |
| Folkersen et al. (PLoS Genet., 2017) | Population study | 3394 | 83 | 79 | Immuno-assay for proteins implicated in cardiovascular diseases |
| de Vries et al. (Hum. Mol. Genet., 2017) | 1,552 European Americans and 1,872 African Americans (ARIC study) | 3424 | 25 | 22 | Mass-spectrometry (small peptide subset of the non-targeted Metabolon metabolomics platform) |
| Ahsan et al. (PLoS Genet., 2017) | Population study | 1033 | 121 | 45 | Antibody-based proximity extension assay |
| Carayol et al. (Nature Comm, 2017) | Obese subjects | 494 | 1129 | 55 | Aptamer-based |
| Benson et al. (Circulation, 2017) | Framingham Heart Study and Malmö Diet and Cancer Study | 2180 | 1129 | 161 | Aptamer-based, array based genotyping and exome seq |
| Patin et al. (Nature Immunology, 2018) | unrelated, Western European ancestry, Milieu Intérieur cohort | 1000 | 87 | 36 | Mean fluorescence intensity (MFI), cell surface marker |
| Sun et al. (Nature, 2018); pre-print on bioRxiv | Interval study (UK blood donors) | 3301 | 2994 | 1927 | Aptamer-based |
| Emilsson et al. (Science, 2018) | AGES Reykjavik study (Islanders over 65) | 5457 | 4137 | 1957 | Aptamer-based |
| Yao et al. (Nature Comm, 2018); pre-print on bioRxiv | Framingham Heart Study | 6861 | 71 | 105 | Immuno-assay for proteins implicated in cardiovascular diseases, replication aptamer-based |
| Ruffieux et al., ASHG 2018 abstract | Optifast Canadian cohort & DiOGenes cohort | 2433 | 1230 | 136 | MS proteomics (130 proteins) and Aptamer-based (1100 proteins) |
| Sliz et al. (bioRxiv, 2018) | Northern Finland Birth Cohort 1966 + meta-analysis in N=13,577 | 5284 | 16 | 16 | Immuno-assay (Luminex / Milliplex, targeting chemokines & cytokines) |
| Zhernakova et al. (Nature Gen. 2018) | LifeLines Dutch population cohort | 1264 | 92 | 214 | Immuno-assay (Olink CVD II panel) |
Tweet This